These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3520369)

  • 1. Pathology of Creutzfeldt-Jakob disease associated with pituitary-derived human growth hormone administration.
    Weller RO; Steart PV; Powell-Jackson JD
    Neuropathol Appl Neurobiol; 1986; 12(2):117-29. PubMed ID: 3520369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study].
    Delisle MB; Fabre N; Rochiccioli P; Doerr-Schott J; Rumeau JL; Bes A
    Rev Neurol (Paris); 1993; 149(10):524-7. PubMed ID: 8023064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [When does the brain atrophy in Creutzfeldt-Jakob disease? (author's transl)].
    Kawai M; Iwata M; Takatsu M; Toyokura Y; Nagashima K
    Rinsho Shinkeigaku; 1981 Aug; 21(8):691-7. PubMed ID: 7035045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications.
    Tintner R; Brown P; Hedley-Whyte ET; Rappaport EB; Piccardo CP; Gajdusek DC
    Neurology; 1986 Jul; 36(7):932-6. PubMed ID: 3520381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creutzfeldt-Jakob disease in recipients of human growth hormone in the United Kingdom: a clinical and radiographic study.
    Markus HS; Duchen LW; Parkin EM; Kurtz AB; Jacobs HS; Costa DC; Harrison MJ
    Q J Med; 1992 Jan; 82(297):43-51. PubMed ID: 1438667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease.
    Manners DN; Parchi P; Tonon C; Capellari S; Strammiello R; Testa C; Tani G; Malucelli E; Spagnolo C; Cortelli P; Montagna P; Lodi R; Barbiroli B
    Neurology; 2009 Apr; 72(16):1425-31. PubMed ID: 19380702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone].
    Roos RA; Wintzen AR; Will RG; Ironside JW; van Duinen SG
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1190-3. PubMed ID: 8692356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathologic anatomy of the central nervous system in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease)].
    Nedz'ved' MK; Protas II; Lystsova EG; Guzov SA; Mil'kamanovich EK
    Arkh Patol; 1985; 47(12):14-20. PubMed ID: 3913407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of Creutzfeldt-Jakob disease.
    Rodda RA
    Clin Exp Neurol; 1977; 14():108-16. PubMed ID: 358185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panencephalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter.
    Mizutani T; Okumura A; Oda M; Shiraki H
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):103-15. PubMed ID: 7012278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A further British case of growth hormone induced Creutzfeldt-Jakob disease.
    Ellis CJ; Katifi H; Weller RO
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1200-2. PubMed ID: 1479400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.
    Croxson M; Brown P; Synek B; Harrington MG; Frith R; Clover G; Wilson J; Gajdusek DC
    Neurology; 1988 Jul; 38(7):1128-30. PubMed ID: 3290702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebellar changes in 50 cases of Creutzfeldt-Jakob disease with emphasis on granule cell atrophy variant.
    Hauw JJ; Gray F; Baudrimont M; Escourolle R
    Acta Neuropathol Suppl; 1981; 7():196-8. PubMed ID: 7013414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathological findings in new variant CJD and experimental transmission of BSE.
    Ironside JW
    FEMS Immunol Med Microbiol; 1998 Jun; 21(2):91-5. PubMed ID: 9684997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MM2-thalamic-type sporadic Creutzfeldt-Jakob disease with widespread neocortical pathology.
    Hirose K; Iwasaki Y; Izumi M; Yoshida M; Hashizume Y; Kitamoto T; Sahashi K
    Acta Neuropathol; 2006 Oct; 112(4):503-11. PubMed ID: 16957926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acquired forms of Creutzfeldt-Jakob disease].
    Mikol J
    Clin Exp Pathol; 1999; 47(3-4):145-51. PubMed ID: 10472734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Panencephalopathy of the Creutzfeldt-Jakob disease type].
    Gertz HJ; Stoltenburg G; Cruz-Sanchez F; Lafuente J; Schopol R
    Nervenarzt; 1988 Feb; 59(2):110-2. PubMed ID: 3283576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood.
    Holmes SJ; Ironside JW; Shalet SM
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):333-5. PubMed ID: 8609514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the white matter lesions of the Creutzfeldt-Jakob disease. Can a new subentity be recognized in man?
    Macchi G; Abbamondi AL; di Trapani G; Sbriccoli A
    J Neurol Sci; 1984 Feb; 63(2):197-206. PubMed ID: 6368755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creutzfeldt-Jakob disease. The neuropathology of a transmission experiment.
    Beck E; Daniel PM; Matthews WB; Stevens DL; Alpers MP; Asher DM; Gajdusek DC; Gibbs CJ
    Brain; 1969; 92(4):699-716. PubMed ID: 4903507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.